TWiV 407: Tar Heels go viral, part one

In the first of two shows recorded at the University of North Carolina in Chapel Hill, Vincent meets up with faculty members to talk about how they got into science, their research on DNA viruses, and what they would be doing if they were not scientists.

You can find TWiV #407 part one at Or watch the video above, or listen below.

[powerpress url=”″]

Click arrow to play
Download TWiV 407a (43 MB .mp3, 71 min)
Subscribe (free): iTunesRSSemail

Become a patron of TWiV!

TWiV 389: Alphabet hepatitis with Stan Lemon

TWiVVincent speaks with Stan Lemon about his career in virology, from early work on Epstein Barr virus, through making essential discoveries about hepatitis A virus, hepatitis C virus, and rhinoviruses, on episode #389 of the science show This Week in Virology.

You can find TWiV #389 at, or listen below.

[powerpress url=”″]

Click arrow to play
Download TWiV 389 (53 MB .mp3, 73 min)
Subscribe (free): iTunesRSSemail, Google Play Music

TWiV 374: Discordance in B

TWiVOn episode #374 of the science show This Week in Virology, the TWiVniks consider the role of a cell enzyme that removes a protein linked to the 5′-end of the picornavirus genome, and the connection between malaria, Epstein-Barr virus, and endemic Burkitt’s lymphoma.

You can find TWiV #374 at

TWiV 344: Glasgwegians go viral

Episode #344 of the science show This Week in Virology was recorded at the Glasgow Science Festival microTALKS, where Vincent spoke with Ruth, Glen, and Esther about their research on viruses and Hodgkin lymphoma, adenovirus structure and entry into cells, and interactions between arthropod borne viruses and their hosts.

You can find TWiV #344 at

TWiV 176: Ave, magi virorum!

On episode #176 of the podcast This Week in Virology, Vincent, Alan, and Rich answer listener email about MS, CFS, EBV, B cells, virii, influenza B, scientific papers, and more.

You can find TWiV #176 at

Persistent viral infections

persistence-of-memoryIn contrast to acute viral infections, persistent infections last for long periods, and occur when the primary infection is not cleared by the adaptive immune response. Varicella-zoster virus, measles virus, HIV-1, and human cytomegalovirus are examples of viruses that cause typical persistent infections. A chronic infection is a type of persistent infection that is eventually cleared, while latent or slow infections last the life of the host.

There is no single mechanism responsible for establishing a persistent infection; a key feature is reduction in host defenses and the ability of the virus to kill cells. Many arenaviruses, such as lymphocytic choriomeningitis virus, do not kill cells and will cause a persistent infection if the host cannot clear the virus. In some persistent viral infections there are alternate cycles of virion production and quiescence. An example is Epstein-Barr virus, the agent of infectious mononucleosis. After the initial bout of fever, sore throat, and swollen lymph glands, the virus establishes a dormant infection in which the viral genome persists in cells of the immune system. Periodically the infection is reactivated and infectious virions are shed in the absence of clinical symptoms. These reactivations lead to transmission of the infection to new hosts.

Bovine viral diarrhea virus infection is another example of how persistence is regulated by the interplay of the host immune response and viral cell killing. This virus establishes a lifelong persistent infection in most of the world’s cattle. The infected animals produce no detectable anti-viral antibody or T-cells. The virus is passed from the mother to fetus early in gestation. Infection does not stimulate the production of interferon (IFN), and therefore the adaptive immune system is not activated. Because infection does not kill cells, a persistent infection ensues.

Many infections persist because viral replication interferes with the function of cytotoxic T-lymphocytes (CTLs), immune cells that are extremely important for clearing viral infections. Infected cells are recognized when CTLs detect viral antigens on the cell surface. This recognition process requires presentation of the viral peptides by major histocompatibilty complex (MHC) class I proteins. Many viral proteins interfere with different steps of the MHC class I pathway, including the synthesis, processing, and trafficking of the protein. Even transport to the cell surface of viral peptides – produced from viral proteins by the large protein complex known as the proteasome – may be blocked.

An amazing example of such immune modulation occurs in cells infected with cytomegalovirus (CMV). This betaherpesvirus causes a common childhood infection of little consequence in healthy individuals. The infection is never cleared, and the virus persistently infects salivary and mammary glands and the kidney. When latently infected individuals are immunosuppressed by drugs or HIV infection, viral replication ensues with life-threatening consequences. CMV persists in the host because the viral genome encodes multiple proteins that interfere with MHC class I presentation of viral antigens. One viral protein blocks translocation of peptides into the lumen of the endoplasmic reticulum, while two other viral proteins cause degradation of MHC class I proteins before they reach the cell surface.

There are many more examples of how virus infections modulate the immune response, leading to persistent infection. Not surprisingly, many of the processing or regulatory steps that are targets of viral modulation were not even known until it was discovered that they were blocked by virus infection.

Peterhans, E. (2003). BVDV and innate immunity Biologicals, 31 (2), 107-112 DOI: 10.1016/S1045-1056(03)00024-1

Bornkamm, G. (2006). The infectious kiss: Newly infected B cells deliver Epstein-Barr virus to epithelial cells Proceedings of the National Academy of Sciences, 103 (19), 7201-7202 DOI: 10.1073/pnas.0602077103

WIERTZ, E. (1996). The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the Cytosol Cell, 84 (5), 769-779 DOI: 10.1016/S0092-8674(00)81054-5